Literature DB >> 6582664

Current concepts in the management of complex retinal detachments.

H Laqua.   

Abstract

Vitrectomy techniques and the use of liquid silicone oil provide important new possibilities in the management of complex retinal detachments including (1) Rhegmatogeneous detachments complicated by vitreous haemorrhages, cataract or an inadequate pupillary opening (2) Traction retinal detachment (3) Combined rhegmatogeneous-traction detachment (4) Proliferative vitreoretinopathy (PVR) (5) Giant tears, especially when the posterior flap is folded over (6) Retinal detachments with posterior retinal breaks. The current concepts in the management of the above retinal detachments are discussed and the specific techniques employed are described.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6582664

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  5 in total

1.  Pars plana vitrectomy for retinal detachment with unseen retinal holes.

Authors:  D Wong; B M Billington; A H Chignell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

2.  A quality of life survey in patients with long-term silicone oil or phthisis bulbi.

Authors:  Jennifer Doyle; Yunfei Yang; Jonathan H Norris; Sher A Aslam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-12       Impact factor: 3.117

3.  Retinal detachment with proliferative vitreoretinopathy: surgical results with scleral buckling, closed vitrectomy, and intravitreous air injection.

Authors:  P C Ho; J W McMeel
Journal:  Br J Ophthalmol       Date:  1985-08       Impact factor: 4.638

4.  Treatment of retinal detachment with macular hole.

Authors:  E Alexandridis; H Kohl-Eisenhut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

5.  Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2.

Authors:  Nicolas Feltgen; Claudia Weiss; Sebastian Wolf; Dominique Ottenberg; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-21       Impact factor: 3.535

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.